Advances in immunotherapy for pancreatic cancer: 2013.
Publication
, Journal Article
DeVito, NC; Saif, MW
Published in: JOP
July 10, 2013
Pancreatic cancer is one of the more difficult malignancies to treat, and there is a great need for less toxic, effective regimens. Immunotherapy has shown potential in the treatment of pancreatic cancer, and at ASCO 2013 there were several progressive advances in its clinical application. Abstracts #3067, #3049, #3007, #4040, #LBA4004, and #3090 will be discussed. New developments in the field of immunotherapy are promising novel treatments for pancreatic neoplasms with tolerable side effect profiles.
Duke Scholars
Published In
JOP
DOI
EISSN
1590-8577
Publication Date
July 10, 2013
Volume
14
Issue
4
Start / End Page
347 / 353
Location
England
Related Subject Headings
- Treatment Outcome
- Survival Analysis
- Pancreatic Neoplasms
- Immunotherapy
- Humans
- Gastroenterology & Hepatology
- Cancer Vaccines
Citation
APA
Chicago
ICMJE
MLA
NLM
DeVito, N. C., & Saif, M. W. (2013). Advances in immunotherapy for pancreatic cancer: 2013. JOP, 14(4), 347–353. https://doi.org/10.6092/1590-8577/1646
DeVito, Nicholas C., and Muhammad Wasif Saif. “Advances in immunotherapy for pancreatic cancer: 2013.” JOP 14, no. 4 (July 10, 2013): 347–53. https://doi.org/10.6092/1590-8577/1646.
DeVito NC, Saif MW. Advances in immunotherapy for pancreatic cancer: 2013. JOP. 2013 Jul 10;14(4):347–53.
DeVito, Nicholas C., and Muhammad Wasif Saif. “Advances in immunotherapy for pancreatic cancer: 2013.” JOP, vol. 14, no. 4, July 2013, pp. 347–53. Pubmed, doi:10.6092/1590-8577/1646.
DeVito NC, Saif MW. Advances in immunotherapy for pancreatic cancer: 2013. JOP. 2013 Jul 10;14(4):347–353.
Published In
JOP
DOI
EISSN
1590-8577
Publication Date
July 10, 2013
Volume
14
Issue
4
Start / End Page
347 / 353
Location
England
Related Subject Headings
- Treatment Outcome
- Survival Analysis
- Pancreatic Neoplasms
- Immunotherapy
- Humans
- Gastroenterology & Hepatology
- Cancer Vaccines